Get started
Author

Mazdak Ganjalıkhani-Hakemi

Observed names: GANJALI KHANI HAKEMI, MAZDAK, Ganjalikhani-Hakemi Mazdak, Hakemi, Mazdak Ganjalikhani, M. G. Hakemi, M. Ganjalikhani Hakemi, M. Ganjalikhani-Hakemi, M. Ganjalikhani‐Hakemi, MAZDAK HAKEMI, Mazdak Ganjalikhani Hakemi, Mazdak G Hakemi, Mazdak G. Hakemi, Mazdak GANJALIKHANI-HAKEM, Mazdak Ganjalikhani Hakemi, Mazdak Ganjalikhani hakemi, Mazdak Ganjalikhani-Hakemi, Mazdak Ganjalikhani-hakemi, Mazdak Ganjalikhani‐Hakemi, Mazdak Ganjalikhani‐hakemi, Mazdak Ganjlikhani Hakemi, Mazdak Ghanjalikhani Hakemi, Mazdak Hakemi, MazdakG Hakemi, MazdakGanjalikhani Hakemi, مزدک گنجعلی خانی حاکمی
Observed institutions: Yeditepe University, Isfahan University of Medical Sciences, Shahrekord University of Medical Sciences, Istanbul Medipol University, Torbat Heydarieh University of Medical Sciences, University of Isfahan
ORCID: 0000-0002-4764-7616
Observed ORCID: 0000-0002-4764-7616
OpenAlex ID: A5000464695
Quercetin with the potential effect on allergic diseases
2020 · Morteza Jafarinia, Mahnaz Sadat Hosseini, et al. · Allergy Asthma and Clinical Immunology · 194
Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Novel Cell-Free Therapy
2020 · Morteza Jafarinia, Fereshteh Alsahebfosoul, et al. · Immunological Investigations · 127
mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients
2021 · Maryam Bidram, Yue Zhao, et al. · Vaccines · 112
PDF
miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis
2015 · Reza Naghavian, Kamran Ghaedi, et al. · PLoS ONE · 94
PDF
Signs of the presence of Th17 cells in chronic periodontal disease
2012 · M. Adibrad, P. Deyhimi, et al. · Journal of Periodontal Research · 89
Therapeutic effects of extracellular vesicles from human adipose‐derived mesenchymal stem cells on chronic experimental autoimmune encephalomyelitis
2020 · Morteza Jafarinia, Fereshteh Alsahebfosoul, et al. · Journal of Cellular Physiology · 85
Bioactive peptides: an alternative therapeutic approach for cancer management
2024 · Nooshin Ghadiri, Moslem Javidan, et al. · Frontiers in Immunology · 74
PDF
TIM-3 in Leukemia; Immune Response and Beyond
2021 · Mahnaz Rezaei, Jiaxiong Tan, et al. · Frontiers in Oncology · 71
The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies
2021 · Mojdeh Soltani, Yue Zhao, et al. · Frontiers in Oncology · 61
PDF
Cytokines (interleukin-9, IL-17, IL-22, IL-25 and IL-33) and asthma
2014 · MazdakGanjalikhani Hakemi, Rahim Farahani, et al. · Advanced Biomedical Research · 57
Analysis of the expression of mir-34a, mir-199a, mir-30c and mir-19a in peripheral blood CD4+T lymphocytes of relapsing-remitting multiple sclerosis patients
2018 · Nooshin Ghadiri, Negaralsadat Emamnia, et al. · Gene · 56
COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect?
2021 · Masoud Etemadifar, Nahad Sedaghat, et al. · Multiple Sclerosis and Related Disorders · 55
PDF
The Role of TIM-3 in Hepatocellular Carcinoma: A Promising Target for Immunotherapy?
2020 · Mazdak Ganjalikhani Hakemi, Morteza Jafarinia, et al. · Frontiers in Oncology · 53
PDF
Comparison of various classifications for patients with common variable immunodeficiency (CVID) using measurement of B-cell subsets
2016 · R. Yazdani, R. Seify, et al. · Allergologia et Immunopathologia · 49
Genetic defects and the role of helper T-cells in the pathogenesis of common variable immunodeficiency
2014 · Roya Sherkat, Reza Yazdani, et al. · Advanced Biomedical Research · 47
Role of apoptosis in common variable immunodeficiency and selective immunoglobulin A deficiency
2016 · Reza Yazdani, Maryam Fatholahi, et al. · Molecular Immunology · 45
Preparation and characterization of a novel nanobody against T-cell immunoglobulin and mucin-3 (TIM-3).
2016 · Vida Homayouni, Mazdak Ganjalikhani-Hakemi, et al. · PubMed Central · 41
PDF
The Review of in Vitro and in Vivo Studies over the Glycyrrhizic Acid as Natural Remedy Option for Treatment of Allergic Asthma
2019 · Saloomeh Fouladi, Mohsen Masjedi, et al. · Iranian Journal of Allergy Asthma and Immunology · 40
Determination of HLA-B27 subtypes in Iranian patients with ankylosing spondylitis.
2008 · Mohamad Hossein Nicknam, Mahdi Mahmoudi, et al. · PubMed · 39
Characteristics of innate lymphoid cells (ILCs) and their role in immunological disorders (an update)
2015 · Reza Yazdani, Mehri Sharifi, et al. · Cellular Immunology · 38
Quercetin potential effects against SARS‐CoV ‐2 infection and COVID ‐19‐associated cancer progression by inhibiting mTOR and hypoxia‐inducible factor‐1α ( HIF ‐1α)
2022 · Hamidreza Zalpoor, Maryam Bakhtiyari, et al. · Phytotherapy Research · 37
Negative regulation of TIM-3 expression in AML cell line (HL-60) using miR-330-5p
2016 · Haniyeh Fooladinezhad, Hossein Khanahmad, et al. · British Journal of Biomedical Science · 37
Optimization of human Th17 cell differentiation in vitro: evaluating different polarizing factors
2011 · Mazdak Ganjalikhani Hakemi, Kamran Ghaedi, et al. · In Vitro Cellular & Developmental Biology - Animal · 36
A Novel CAR Expressing NK Cell Targeting CD25 With the Prospect of Overcoming Immune Escape Mechanism in Cancers
2021 · Moein Dehbashi, Zohreh Hojati, et al. · Frontiers in Oncology · 32
PDF
Combinatorial delivery of antigen and TLR agonists via PLGA nanoparticles modulates Leishmania major-infected-macrophages activation
2021 · Asal Katebi, Reyhaneh Varshochian, et al. · Biomedicine & Pharmacotherapy · 32
Works count: 160
Citation count: 2,641
H-index: 28
I10-index: 65
Year
Topic
Type